Total Payments
$1,503
2024 Payments
$648.20
Companies
23
Transactions
82
Medicare Patients
2,470
Medicare Billing
$158,426
Payment Breakdown by Category
Food & Beverage$1,503 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,503 | 82 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $332.26 | 18 | $0 (2024) |
| ABBVIE INC. | $263.64 | 14 | $0 (2024) |
| Lilly USA, LLC | $133.96 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $94.31 | 4 | $0 (2023) |
| Amgen Inc. | $84.19 | 5 | $0 (2024) |
| Abbott Laboratories | $60.71 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $60.55 | 3 | $0 (2024) |
| Medtronic, Inc. | $52.44 | 2 | $0 (2024) |
| Scilex Pharmaceuticals Inc. | $42.39 | 2 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $41.64 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $648.20 | 33 | ABBVIE INC. ($183.28) |
| 2023 | $403.10 | 22 | ABBVIE INC. ($80.36) |
| 2022 | $240.12 | 13 | Novo Nordisk Inc ($67.81) |
| 2021 | $212.01 | 14 | Novo Nordisk Inc ($43.35) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $34.13 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Inflammation | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Diabetes | ||||||
| 05/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Obesity | ||||||
| 05/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Biological | ||||||
| 05/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Respiratory | ||||||
| 05/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 487 | 700 | $145,265 | $38,488 |
| 2022 | 10 | 495 | 708 | $143,525 | $37,340 |
| 2021 | 15 | 625 | 954 | $172,476 | $43,562 |
| 2020 | 13 | 863 | 1,217 | $167,483 | $39,037 |
Total Patients
2,470
Total Services
3,579
Medicare Billing
$158,426
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 323 | $89,649 | $18,677 | 20.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $9,994 | $5,926 | 59.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 51 | 51 | $18,671 | $5,294 | 28.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 29 | 29 | $6,264 | $2,198 | 35.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 56 | $3,164 | $1,634 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 38 | $7,448 | $1,552 | 20.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 18 | 18 | $4,410 | $1,137 | 25.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 21 | 21 | $1,134 | $612.57 | 54.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 45 | 58 | $964.00 | $487.20 | 50.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 23 | 23 | $920.00 | $481.80 | 52.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 26 | $1,706 | $221.93 | 13.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 14 | $690.00 | $191.10 | 27.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 22 | $251.00 | $75.02 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 358 | $99,524 | $19,820 | 19.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 70 | 70 | $23,590 | $7,401 | 31.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $3,972 | $3,059 | 77.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 68 | 74 | $3,700 | $2,289 | 61.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 67 | 73 | $2,701 | $2,054 | 76.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 16 | 16 | $4,000 | $1,078 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 25 | $4,900 | $1,066 | 21.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $481.00 | $364.80 | 75.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 37 | 40 | $360.00 | $118.23 | 32.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 20 | 27 | $297.00 | $90.95 | 30.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 209 | 490 | $131,681 | $30,797 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 32 | 32 | $10,707 | $3,277 | 30.6% |
About Anna Bruton, ANP-C
Anna Bruton, ANP-C is a Adult Health healthcare provider based in Clayton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2012. The National Provider Identifier (NPI) number assigned to this provider is 1023354024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anna Bruton, ANP-C has received a total of $1,503 in payments from pharmaceutical and medical device companies, with $648.20 received in 2024. These payments were reported across 82 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,503).
As a Medicare-enrolled provider, Bruton has provided services to 2,470 Medicare beneficiaries, totaling 3,579 services with total Medicare billing of $158,426. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Clayton, NC
- Active Since 12/19/2012
- Last Updated 05/06/2021
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1023354024
Products in Payments
- Ozempic (Drug) $175.02
- QULIPTA (Drug) $145.01
- Wegovy (Drug) $98.66
- REXULTI (Drug) $94.31
- MOUNJARO (Drug) $78.15
- JARDIANCE (Drug) $71.01
- VRAYLAR (Drug) $67.91
- Otezla (Drug) $65.52
- AIRSUPRA (Drug) $60.55
- INTELLIS ADAPTIVESTIM (Device) $52.44
- Rybelsus (Drug) $43.15
- ZTLido (Drug) $42.39
- XIFAXAN (Drug) $41.64
- QUVIVIQ (Drug) $41.53
- FREESTYLE LIBRE 2 (Device) $40.47
- XARELTO (Drug) $31.13
- BELSOMRA (Drug) $27.13
- Azstarys (Drug) $22.78
- Veozah (Drug) $21.82
- TRINTELLIX (Drug) $21.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Clayton
Mrs. Kellie Cochran, A.n.p, A.N.P
Adult Health — Payments: $525.33
Adult Health $525.33
Pamila Mcintyre, A-Gnp-C, A-GNP-C
Adult Health — Payments: $102.90
Adult Health $102.90
Ms. Mary Bauer, Rn, Msn, Aprn, RN, MSN, APRN
Adult Health
Adult Health
Ms. Michelle Paquin, Msn, Arnp, Bc, Anp, MSN, ARNP, BC, ANP
Adult Health
Adult Health
Mrs. Karen Blair, Canp, CANP
Adult Health
Adult Health
Ms. Nathalie Archangel-Montijo, Np, NP
Adult Health
Adult Health